Research in homeopathy at Life Force

Homeopathic medicines, known as nosodes, were tested against bacteria from urinary infections in the laboratory. Many nosodes demonstrated antibacterial effects, and drugs were able to slow or halt the growth of certain bacteria. Surprisingly, their effect was comparable to that of a commonly used antibiotic, suggesting a possible role in treating infections due to their antimicrobial action.

Conclusion:

• Efficacy ranging from 94% to 60% against different bacterial strains was demonstrated.
• This study unveils the therapeutic potential of homeopathic medicines against antibiotic-resistant bacterial strains.

This study tested whether a homeopathic COVID-19 nosode called BiosimCovex is safe in animals. Researchers gave mice, rats, and rabbits different doses, such as one-time and repeated doses, and watched for any toxic effects. They found no significant toxic effects, suggesting the nosode was safe at the tested doses in this animal model.

Conclusion:

• No toxicity was documented using acute, subacute, and repeated dose studies
• Proven safe to administer orally

This review highlights that many old homeopathic medicines lack clear information about their source and preparation, making them hard to reproduce reliably. It describes a need for fresh provings, and better-quality control to improve safety and consistency in homeopathic practice

Conclusions:

• Most traditional homeopathic drugs are hard to reproduce due to vague source/preparation records
• The authors call for modern standardisation, fresh provings, and better tracking to ensure quality and reliability

This Phase I study, conducted in the early stages, administered a homeopathic COVID-19 nosode called BiosimCovex orally to 10 healthy volunteers for 3 days to assess its safety and potential to trigger immune responses. No serious side effects were seen, and some immune markers (like IL-6 and CD4 cells) changed over time, suggesting possible biological effects worth further study

Conclusions:

• BiosimCovex appeared safe with no serious adverse effects in the small group tested
• Changes in immune markers suggest possible signals that should be explored in larger studies.

This feasibility study tested homeopathic medicines (like Bryonia alba 30c and a coronavirus nosode/ BiosimCovex 30c) against a placebo in quarantined individuals after exposure to COVID-19. The groups taking Bryonia alba or BiosimCovex showed a trend toward fewer COVID-19 cases and shorter illness than the placebo

Conclusions:

• Homeopathic nosode BiosimCovex and Bryonia alba 30c showed signals of potentially lowering COVID-19 incidence and disease prevention
• Shortening the course of disease symptomatology in a COVID-19-exposed population

This study is an open-label trial to evaluate the safety and provoking symptoms of Coronavirus nosode. The symptoms reported by volunteers were mild to severe but reversible and matched the symptoms produced by the viral infection. There were no serious/fatal adverse events during the study. The basic biochemistry and Liver Function tests were not affected by the Nosode.

Conclusions:

• A new nosode developed during a pandemic condition produced certain symptoms in the homeopathic pathogenetic trial
• The safe use of the nosode is documented

In May 2020, at the beginning of the COVID-19 pandemic,  scientists prepared three types of homeopathic coronavirus nosodes from (1) a clinical sample, (2) a heat-inactivated virus strain, and (3) the spike protein. They checked that the materials were free of detectable virus RNA at higher dilutions, following homeopathic preparation methods, to make them safe for future research

Conclusions:

• Three SARS-CoV-2-derived nosodes were successfully prepared and standardized under biosafety conditions
• These nosode preparations showed no detectable RNA at potentized levels, thus rendering them safe for human consumption

This study used UV-visible, fluorescence, and Raman spectroscopy to examine homeopathic preparations (potentized ethanol-water mixtures with sulfur). The potentized samples showed changes in light absorption, fluorescence, and molecular interactions compared to controls, suggesting altered physicochemical properties due to potentization

Conclusions:

• Potentized ethanol–water samples showed clear changes in UV/fluorescence and Raman signals, indicating altered molecular behavior
• Raman spectroscopy indicated a significant change in electronic configuration as well as the intermolecular interaction in the liquid phase in potentized preparations
• Based on the study results, scientists hypothesize that some structural changes may occur in potentized samples.

Homeopathic nosode preparations were tested at ACTREC (Tata, Mumbai), made from cancer-related substances (like HIV nosode, Hepatitis C nosode, Carcinosin, and cancer tissue) on various human cancer cell lines. Many of these potentized preparations significantly slowed the growth of several cancer cell types in vitro, suggesting possible anticancer activity

Conclusions:

• High-dilution preparations of certain carcinogen-derived nosodes showed measurable anticancer effects in multiple cancer cell lines
• These findings support further research into their mechanisms and potential applications in cancer biology

This in vitro study tested several homeopathic medicines (like China officinalis, Chelidonium, Arsenicum album, and a specially made malaria nosode) to see if they stop malaria parasite activity using a chemical assay that mimics parasite growth. The results showed varying levels of inhibition of heme crystallization, a process important to malaria parasites, suggesting some preparations may affect parasite biology in vitro

Conclusions:

• Some homeopathic preparations showed measurable inhibition in a lab antimalarial assay
• These findings support the role of homeopathic medicine in anti-malarial activity

KEY FINDINGS:

• Kills Liver Cancer Cells – Triggers natural self-destruct (Apoptosis)
• Selective & Safe – Almost ZERO harm to normal healthy liver cells
• Blocks Cancer Growth – Strongly reduces Telomerase & Topoisomerase II

SPECIAL PROOF: NOT PLACEBO!

Same test run with placebo (just dilated alcohol) → ZERO effect

This proves Homeopathy produces REAL biological results!

CONCLUSION:

Hepatitis C Nosode developed by Dr. Rajesh Shah shows powerful anticancer potential against liver cancer cells in vitro -one of many scientific validations of Homeopathy. It was not a human trial. This was a laboratory (in vitro) study on cancer cell lines.

Source: Mondal et al., Journal of Integrative Medicine (2016)

A newly prepared Hepatitis C nosode (30C) was tested on cancer cells grown in vitro. It reduced the growth of liver cancer cells (HepG2) and triggered signs of programmed cell death (apoptosis) by affecting cancer-linked enzymes and cellular pathways. Normal liver cells were significantly less affected, suggesting a selective anticancer activity of the Hepatitis C nosode in vitro.

Conclusions:

• Hepatitis C 30C nosode showed anticancer effects in liver cancer cells by inducing apoptosis and altering telomerase/Topoisomerase II enzymes
• Hep C 30 has demonstrable anticancer effects against liver cancer cells in vitro and potential use in cancer treatment

This research utilised Wistar rats to test the homeopathic preparations Capsaicin and Magnesium phosphoricum in an experimentally induced arthritis model to determine if they reduce joint swelling and inflammation. Diclofenac was used as a positive control. Magnesium phosphoricum showed a significant reduction in swelling, comparable to the standard anti-inflammatory drug, while other ultra-diluted treatments had less effect.

Conclusions:

• Magnesium phosphoricum significantly reduced arthritis symptoms in rats
• Diclofenac and Magnesium phosphoricum showed a significant reduction in the arthritic index on days 7 and 21
• Ultra-diluted homoeopathic preparation of Magnesium phosphoricum exhibited definite antiarthritic activity.

A controlled proving trial of homeopathic preparation of capsaicin and Dihydrocapsaicin was conducted in 22 healthy volunteers. Symptoms were recorded over 5 weeks. Those who took the potentized medicine (verum) reported distinct symptoms similar to those caused by the crude substance, suggesting the preparation had measurable effects compared with a placebo

 Conclusions:

• The potentized capsaicin/Dihydrocapsaicin produced significant symptom patterns versus placebo in healthy volunteers
• These findings support the basic homeopathic idea that such potentized substances may trigger characteristic effects and can be used as homeopathic treatment

This in vitro study evaluated whether highly diluted homeopathic medicines can change the melanin content in murine B16F10 melanoma cells. Researchers treated melanoma cells with homeopathic medicines and measured melanin levels to see if the preparations affected cell behavior compared to untreated controls. The goal was to explore the potential effects of potentialized treatments on pigmentation and determine their biological effects.

Conclusions:

• Some ultra-diluted, potentized preparations altered melanin content in melanoma cells, suggesting a measurable effect in vitro
• These findings support further research into how potentized homeopathic preparations might influence cell functions and pigmentation pathways

This double-blind, randomized, placebo-controlled trial study involves the administration of potentized hydroquinone in healthy volunteers to see what symptoms it produces. The goal was to derive clear symptom patterns (“proving data”) that could guide clinical use. Volunteers taking the medicine reported distinct symptoms compared to placebo, and no serious safety issues were found

 Conclusions:

• The Hydroquinone 30 C homeopathic preparation produced qualitatively distinct symptom patterns that could be used for clinical prescribing
• The trial’s Quantitative and Qualitative Pathogenetic Indices offer a structured way to evaluate proven symptoms

This double-blind, randomized, placebo-controlled homeopathic drug-proving study evaluated a Hepatitis C nosode (30C, newly prepared by Dr Rajesh Shah) in healthy volunteers. Those taking the nosode reported distinct, quantifiable symptom changes compared to the placebo, generating guiding symptom data for clinical use. Safety was documented, and the method allowed reproducible nosode preparation.

Conclusions:

• The Hepatitis C nosode produced significantly more symptoms with a pathogenetic effect per volunteer in the verum group 9
• Verum arm produced more characteristic symptoms than the placebo, supporting homeopathic proving methodology
• The standardization method provides reproducible preparation and symptom data that may guide clinical prescribing to clinicians in practice

This is a randomized, double-blind, placebo-controlled trial of a homeopathic HIV nosode (30C) in healthy volunteers, conducted at Life Force. HIV nosode was administered once weekly for 4 weeks, and symptoms produced were recorded systemically. Those taking the nosode (verum) reported a larger number of distinct symptoms than those taking the placebo, helping create a symptom profile that homeopaths may use when prescribing this remedy. Safety was also monitored.

 Conclusions:

• The HIV nosode produced distinct symptom patterns vs placebo, useful for homeopathic prescribing.
• The number of symptoms reported in the verum group was 130, in the placebo group 60. Quantitative pathogenetic index was 0.285 in the verum group, 0.238 in the placebo group; qualitative pathogenetic index was 0.1402 in the verum group as compared to placebo (0.0907).
• It was well tolerated with no serious adverse effects in this trial.

This article argues that two widely used homeopathic nosodes, Tuberculinum and Psorinum, should be updated in accordance with modern standards, as their sources and methods are unclear or unknown. The author suggests re-evaluating and standardizing these nosodes to improve reproducibility and clinical reliability.

Conclusions:

• Tuberculinum and Psorinum nosodes need to be prepared from newly identified sources
• Need for clear standards and a well-defined preparation method
• Updating these nosodes could enhance reproducibility and clinical utility in homeopathic practice

This article describes a systematic, modern way to prepare homeopathic nosodes (medicines made from disease-related biological sources) using current laboratory technology. It details how to identify pure source material, quantify it, and standardize the dilution/potentization process to make nosodes that are consistent and safe for research and clinical use.

Conclusions:

• A clear, reproducible method for preparing nosodes from HIV, Hepatitis C, and Mycobacterium tuberculosis was established
• This modern preparation method can help set guidelines for nosode production in homeopathic pharmacopeias